<SANITIZED>
Document Type:
Collection:
Document Number (FOIA) /ESDN (CREST):
06159136
Release Decision:
RIPPUB
Original Classification:
U
Document Page Count:
12
Document Creation Date:
March 9, 2023
Document Release Date:
February 27, 2020
Sequence Number:
Case Number:
F-2009-01030
Publication Date:
April 15, 2005
File:
Attachment | Size |
---|---|
SANITIZED[15789380].pdf | 123.99 KB |
Body:
�
ArAr AireApr:;vzdZor Release: 2.00/02/25 C06159,6
r
ROUTING
TO:
NAME AND ADDRESS
DATE
INITIALS
1
2
3
4
ACTION
DIREC'TFEPLY
PREPARE REPLY
APPROVAL
DISPATCH
RECOMMENDATION
commegr
RE
FETURN
CONCURRENCE
INFORMTION
SIGNATURE
REMARKS:
FROM: NAME, ADDRESS, AND PHONE NO.
DATE
(b)(1)
(b)(3)
Handle Via
(b)(3)
CONTROL NO
COPY
Channels
(b)(3)
Access to this document will be restricted to
those approved for the following specific activities:
NATIONAL SECURITY INFORMATION
Unauthorized Disclosure Subject to Criminal Sanctions
THIS COVER SHEET IS UNCLASSIFIED WHEN BLANK
rArAllrAPPor
OF
AMN 02315
Approved for Release: 2020/02/25 C06159136
j-rK. elakr0 lid; 47RM
Approved for Release: 2020/02/25 C06159136 NO. 532
-140P-SEeftErTh
(b)(1)
(b)(3)
blgsPtillefrelpIst-
To:
Organization:
Phone:
Fax
me.
From:
Organization:
Phone:
Fax:
FAX COVER SHEET
Central Intelligence Agency
Washington, DC 20505
15 April 2005
DOJ Command Center
For
Office of Legal Counsel
U.S. Department of Justice
�
(b)(3)
(b)(6) Legal Group
DO Counterterrorist Center
(b)(3)
P.1
Number of pages (including cover sheet):
(b)(6)�
Comments: ZESR47) Answers to your questions.
A
1. More on successes.
2. Intel value of Gul.
NOTICE, TO RECIPIENT
AMN 02316
This information is property of the United States intended solely for the use glebe entity or person named above and also may be attorney-client
privileged or otherwise exentprfrom disclosure under applicable /am If you are not the WU:tided recipient of thi,v facsimile, or die employee or
agent responsible for delivering the message w the intended recipient, you ore hereby notified that receipt of this message is no/a waiver or release
41, my applicable privilege or exemption from disclosure, and that review. dissemination, distribution, or copying of this communication is strictly
Med. Ifyou have received this material in error. please nonfy this Vice en the (Mot, l telephone number (collect) for instructions regarding its
rn Or destruction, Thank you.
4-011-5EFEE-Ti
(b)(1)
(b)(3)� (b)(3)
4441+
(b)(6)
(b)(3)
(b)(6)
Approved for Release: 2020/02/25 C06159136
mrm.10.G0= 110i4dH1
' Approved for Release: 2020/02/25 C06159136
� (b)(3)
SECRET/ NOFORNMVIR
NO.532 P.2
Janat Gul
(b)(1)
Janet Gul--arrested (b)(3) on June
2004 and transferred to US custody --was a key Tallinn and
Islamic Movement of Uzbekistan (Ii U) facilitator. Various reporting Indicates
that Gul worked as a facilitator and courier for al-Qa'ida field commander and
senior leader 'Abd al-Hadi al-Iraqi; at the same time, he was also aiding the IMU
and former Taliban leadership, Since his detention, Gul has provided information
that has been contained In some 70 Intelligence reports about Taliban, IMU, and
al-Qatida associates and members in Pakistan; however, 20 percent of those
reports are statements of non-recognition of individuals. Moreover, during most
of Gul's debriefings, he has sought to minimize his knowledge of extremist
activities and has provided largely non-incriminating information about his
involvement in their networks,
� Gul has provided information about his efforts to transfer a small number of
Arab fighters to Shkai, Pakistan to join 'Abd al-Hadi al-Iraqi, his attempt to
deliver a letter from the IMU leader to the Taliban leadership containing a
request for SAM-7 missiles, and other efforts to facilitate the travel of
mujahidin or procurement of materiel. He has provided few details, however,
on the individuals he employed when facilitating the movement of Arab
fighters and equipment.
�
(b)(1)
(b)(3)
(b)(1) *
(b)(3),
(b)(1)
(b)(3)
(b)(3)
(1)(3) AMN 02317
SECRET// (b)(3) ,NOFORNU/MR
Approved for Release: 2020/02/25 C06159136
.t..rx.i.eum 10:49RM
Approved for Release: 2020/02/25 C06159136
SECRET/
NOFORLs1//MR
NO.532 P.3
2
� SECRET (b)(3) 10FORIVIVIR
AMN 02318
(b)(1)
(b)(3)
Approved for Release: 2020/02/25 C06159136
Approved for Release: 2020/02/25 C06159136
(b)(1)
(b)(3)
(b)(6)
(b)(7)(a)
(b)(7)(b)
(b)(7)(c)
Approved for Release: 2020/02/25 C06159136
Approved for Release: 2020/02/25 C06159136
(b)(1)
(b)(3)
(b)(6)
(b)(7)(a)
(b)(7)(b)
(b)(7)(c)
Approved for Release: 2020/02/25 C06159136
Approved for Release: 2020/02/25 C06159136
(b)(1)
(b)(3)
(b)(6)
(b)(7)(a)
(b)(7)(b)
(b)(7)(c)
Approved for Release: 2020/02/25 C06159136
Approved for Release: 2020/02/25 C06159136
(b)(1)
(b)(3)
(b)(6)
(b)(7)(a)
(b)(7)(b)
(b)(7)(c)
Approved for Release: 2020/02/25 C06159136
Approved for Release: 2020/02/25 C06159136
(b)(1)
(b)(3)
(b)(6)
(b)(7)(a)
(b)(7)(b)
(b)(7)(c)
Approved for Release: 2020/02/25 C06159136
Approved for Release: 2020/02/25 C06159136
(b)(1)
(b)(3)
(b)(6)
(b)(7)(a)
(b)(7)(b)
(b)(7)(c)
Approved for Release: 2020/02/25 C06159136
Approved for Release: 2020/02/25 C06159136
(b)(1)
(b)(3)
(b)(6)
(b)(7)(a)
(b)(7)(b)
(b)(7)(c)
Approved for Release: 2020/02/25 C06159136
Approved for Release: 2020/02/25 C06159136
(b)(1)
(b)(3)
(b)(6)
(b)(7)(a)
(b)(7)(b)
(b)(7)(c)
Approved for Release: 2020/02/25 C06159136